4.8 Review

Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage

期刊

FRONTIERS IN IMMUNOLOGY
卷 11, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2020.00734

关键词

renal aging; complement system; AKI-to-CKD transition; cellular senescence and SASP; complement inhibition therapy

资金

  1. University of Bari Aldo Moro
  2. Italian Ministry of Health (Giovani Ricercatori 2011-2012) [GR-2011-02351027]
  3. Regional Strategic Grant, Apulia Region [PSR 094]
  4. Fondazione Cassa di Risparmio di Puglia

向作者/读者索取更多资源

The aberrant activation of complement system in several kidney diseases suggests that this pillar of innate immunity has a critical role in the pathophysiology of renal damage of different etiologies. A growing body of experimental evidence indicates that complement activation contributes to the pathogenesis of acute kidney injury (AKI) such as delayed graft function (DGF) in transplant patients. AKI is characterized by the rapid loss of the kidney's excretory function and is a complex syndrome currently lacking a specific medical treatment to arrest or attenuate progression in chronic kidney disease (CKD). Recent evidence suggests that independently from the initial trigger (i.e., sepsis or ischemia/reperfusions injury), an episode of AKI is strongly associated with an increased risk of subsequent CKD. The AKI-to-CKD transition may involve a wide range of mechanisms including scar-forming myofibroblasts generated from different sources, microvascular rarefaction, mitochondrial dysfunction, or cell cycle arrest by the involvement of epigenetic, gene, and protein alterations leading to common final signaling pathways [i.e., transforming growth factor beta (TGF-beta), p16(ink4a), Wnt/beta-catenin pathway] involved in renal aging. Research in recent years has revealed that several stressors or complications such as rejection after renal transplantation can lead to accelerated renal aging with detrimental effects with the establishment of chronic proinflammatory cellular phenotypes within the kidney. Despite a greater understanding of these mechanisms, the role of complement system in the context of the AKI-to-CKD transition and renal inflammaging is still poorly explored. The purpose of this review is to summarize recent findings describing the role of complement in AKI-to-CKD transition. We will also address how and when complement inhibitors might be used to prevent AKI and CKD progression, therefore improving graft function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Food Science & Technology

Fecal Microbiota Transplantation in Reducing Uremic Toxins Accumulation in Kidney Disease: Current Understanding and Future Perspectives

Gianvito Caggiano, Alessandra Stasi, Rossana Franzin, Marco Fiorentino, Maria Teresa Cimmarusti, Annamaria Deleonardis, Rita Palieri, Paola Pontrelli, Loreto Gesualdo

Summary: The gut microbiome plays a crucial role in kidney disease, with dysbiosis-related uremic toxins and pro-inflammatory mediators contributing to kidney function deterioration. The toxicity of uremic compounds has been well-documented in various pathophysiological mechanisms, such as cardiovascular injury, metabolic dysfunction, and inflammation. Accumulating evidence supports the use of fecal microbiota transplantation (FMT) as a promising treatment to reduce uremic toxin accumulation. This review presents the current state of FMT application in kidney disease to restore a healthy microbiome and reverse uremic toxin retention.

TOXINS (2023)

Review Endocrinology & Metabolism

Recent advances in molecular mechanisms of acute kidney injury in patients with diabetes mellitus

Barbara Infante, Francesca Conserva, Paola Pontrelli, Serena Leo, Alessandra Stasi, Marco Fiorentino, Dario Troise, Andrea dello Strologo, Carlo Alfieri, Loreto Gesualdo, Giuseppe Castellano, Giovanni Stallone

Summary: Several insults, especially diabetes, can lead to acute kidney injury (AKI) in both native kidney and transplant patients. High glucose levels disrupt signaling pathways within the kidney, causing maladaptive repair and kidney dysfunction. Diabetic kidneys are often vulnerable to hypoxia due to reduced oxygenation, vascular damage, and increased inflammation. Patients with a history of AKI have a worse prognosis, highlighting the importance of monitoring diabetic patients for AKI. This review focuses on the molecular mechanisms underlying increased susceptibility to AKI in diabetes and the potential biomarkers for diagnosis and prognosis.

FRONTIERS IN ENDOCRINOLOGY (2023)

Review Biochemistry & Molecular Biology

The Human Virome and Its Crosslink with Glomerulonephritis and IgA Nephropathy

Fabio Sallustio, Angela Picerno, Francesca Montenegro, Maria Teresa Cimmarusti, Vincenzo Di Leo, Loreto Gesualdo

Summary: The human virome, consisting of prokaryotes, viruses, fungi, and parasites, is intricately connected with the human host. Different viral community states have been identified as indicators of health or undesirable outcomes for the host. The virome can collaborate with the human host in maintaining mutualistic functions and preserving human health. This Review explores the role of viruses in health and disease, the relationship between the virobiota and immune system control, and the potential molecular mechanisms linking viruses to glomerulonephritis and IgA nephropathy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Virology

Efficacy of Remdesivir and Neutralizing Monoclonal Antibodies in Monotherapy or Combination Therapy in Reducing the Risk of Disease Progression in Elderly or Immunocompromised Hosts Hospitalized for COVID-19: A Single Center Retrospective Study

Davide Fiore Bavaro, Lucia Diella, Alessandra Belati, Giuliana Metrangolo, Laura De Santis, Vito Spada, Michele Camporeale, Angelo Dargenio, Gaetano Brindicci, Flavia Balena, Deborah Fiordelisi, Fabio Signorile, Giacomo Loseto, Crescenza Pasciolla, Carla Minoia, Immacolata Attolico, Tommasina Perrone, Simona Simone, Maria Rendina, Nicoletta Giovine, Francesco Di Gennaro, Pellegrino Musto, Attilio Guarini, Alfredo Di Leo, Loreto Gesualdo, Maria Dell'Aera, Annalisa Saracino

Summary: Remdesivir (REM) and monoclonal antibodies (mAbs) may alleviate severe COVID-19 in at-risk hospitalized patients, particularly in elderly or immunocompromised hosts. The use of REM and mAbs was associated with a reduced risk of severe COVID-19, and the combination therapy was particularly beneficial for immunocompromised patients.

VIRUSES-BASEL (2023)

Review Cell Biology

The Mission of Long Non-Coding RNAs in Human Adult Renal Stem/Progenitor Cells and Renal Diseases

Francesca Giannuzzi, Silvia Maiullari, Loreto Gesualdo, Fabio Sallustio

Summary: Long non-coding RNAs (lncRNAs) are a diverse group of transcripts that regulate gene expression at different levels in various cellular contexts and biological processes. Understanding their mechanisms of action and their involvement in disease can lead to potential therapeutic approaches. In the context of renal pathogenesis, the role of lncRNAs is still not well understood, particularly in healthy kidneys and adult renal stem/progenitor cells (ARPC). This review provides an overview of lncRNA biogenesis, degradation, and functions, focusing on their functional roles in kidney diseases and their regulation of stem cell biology, with a specific emphasis on the lncRNA HOTAIR's ability to prevent senescence in ARPC.
Article Cell Biology

Human Adult Renal Progenitor Cells Prevent Cisplatin-Nephrotoxicity by Inducing CYP1B1 Overexpression and miR-27b-3p Down-Regulation through Extracellular Vesicles

Rossana Franzin, Alessandra Stasi, Giuseppe De Palma, Angela Picerno, Claudia Curci, Serena Sebastiano, Monica Campioni, Antonella Cicirelli, Alessandro Rizzo, Vito Francesco Di Lorenzo, Paola Pontrelli, Giovanni Battista Pertosa, Giuseppe Castellano, Loreto Gesualdo, Fabio Sallustio

Summary: In this study, it was found that tubular adult renal progenitor cells (tARPC) can influence the gene expression of renal proximal tubular cell (RPTEC) during cisplatin-induced nephrotoxicity via the release of extracellular vesicles (EV) enriched with CYP1B1 and miR-27b-3p. CYP1B1 expression was correlated with renal function.
Article Infectious Diseases

Impact of a Pro-Active Infectious Disease Consultation on the Management of a Multidrug-Resistant Organisms Outbreak in a COVID-19 Hospital: A Three-Months Quasi-Experimental Study

Davide Fiore Bavaro, Nicolo De Gennaro, Alessandra Belati, Lucia Diella, Roberta Papagni, Luisa Frallonardo, Michele Camporeale, Giacomo Guido, Carmen Pellegrino, Maricla Marrone, Alessandro Dell'Erba, Loreto Gesualdo, Nicola Brienza, Salvatore Grasso, Giuseppe Columbo, Antonio Moschetta, Giovanna Elisiana Carpagnano, Antonio Daleno, Anna Maria Minicucci, Giovanni Migliore, Annalisa Saracino

Summary: The introduction of a pro-active Infectious Disease (ID) consultation in a COVID-19 hospital can reduce the mortality risk of patients with MDROs infections by optimizing treatment and diagnostic strategies to improve patient outcomes.

ANTIBIOTICS-BASEL (2023)

Review Biochemistry & Molecular Biology

Acute Kidney Injury in Kidney Transplant Patients in Intensive Care Unit: From Pathogenesis to Clinical Management

Marco Fiorentino, Francesca Bagagli, Annamaria Deleonardis, Alessandra Stasi, Rossana Franzin, Francesca Conserva, Barbara Infante, Giovanni Stallone, Paola Pontrelli, Loreto Gesualdo

Summary: Kidney transplantation is the preferred treatment for end-stage renal disease (ESRD). Kidney transplant recipients (KTRs) are at a higher risk of ICU admission, mainly in the late post-transplant period. Urosepsis and bloodstream infections are the main reasons for ICU admissions, and side effects of immunosuppressive treatment should also be accounted for. AKI incidence is common in KTRs during ICU stay, and in-hospital mortality can be high. The present review aims to explore the impact of AKI on outcomes in KTRs and provide insights into its diagnosis, management, and immunosuppression modulation.

BIOMEDICINES (2023)

Article Medicine, General & Internal

Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project

Alessandra Stasi, Marco Fiorentino, Rossana Franzin, Francesco Staffieri, Sabrina Carparelli, Rosa Losapio, Alberto Crovace, Luca Lacitignola, Maria Teresa Cimmarusti, Francesco Murgolo, Monica Stufano, Cesira Cafiero, Giuseppe Castellano, Fabio Sallustio, Chiara Ferrari, Mario Ribezzi, Nicola Brienza, Annalisa Schirinzi, Francesca Di Serio, Salvatore Grasso, Paola Pontrelli, Cyrille Tupin, Ronald Barbaras, Constance Keyserling-Peyrottes, Antonio Crovace, Loreto Gesualdo

Summary: CER-001 shows promise as a therapeutic strategy for sepsis management, improving outcomes and mitigating inflammation and organ damage.

BMC MEDICINE (2023)

Article Critical Care Medicine

Recovery after AKI: Effects on outcomes over 15 years

Sadudee Peerapornratana, Marco Fiorentino, Priyanka Priyanka, Raghavan Murugan, John A. Kellum

Summary: This study aimed to investigate the impact of kidney recovery on mortality, dialysis, and kidney transplantation up to 15 years after AKI. The findings showed that the recovery status of AKI at hospital discharge was associated with long-term mortality, with the highest mortality rate observed in patients who did not recover. These results have important implications for acute care, follow-up, and endpoint selection in clinical trials.

JOURNAL OF CRITICAL CARE (2023)

Article Urology & Nephrology

Extracorporeal blood purification therapies for sepsis-associated acute kidney injury in critically ill patients: expert opinion from the SIAARTI-SIN joint commission

Silvia De Rosa, Marita Marengo, Marco Fiorentino, Vito Fanelli, Nicola Brienza, Enrico Fiaccadori, Giacomo Grasselli, Santo Morabito, Vincenzo Pota, Stefano Romagnoli, Fabrizio Valente, Vincenzo Cantaluppi, SIAARTI-SIN Joint Commission

Summary: Sepsis-associated acute kidney injury (AKI) is a life-threatening condition with high morbidity and mortality in critically ill patients. Despite the development of various extracorporeal blood purification therapies for sepsis and sepsis-associated AKI, there are still unresolved questions regarding the indications and timing of renal replacement therapy, optimal dialysis dose, and rationale for using these therapies in septic patients without AKI. There is also growing interest in novel blood purification therapies using adsorption devices for specific mediators clearance and antibiotic removal. A joint commission of the Italian Society of Anesthesiology and Critical Care and the Italian Society of Nephrology addressed these issues, proposed recommendations, and developed a framework for future research in this field.

JOURNAL OF NEPHROLOGY (2023)

Review Hematology

Enhancing Immune Protection in Hemodialysis Patients: Role of the Polymethyl Methacrylate Membrane

Rossana Franzin, Alessandra Stasi, Gianvito Caggiano, Elena Squiccimarro, Vincenzo Losappio, Marco Fiorentino, Carlo Alfieri, Giovanni Stallone, Loreto Gesualdo, Giuseppe Castellano

Summary: ESRD is associated with immune dysregulation caused by factors such as uremia and hemodialysis membrane biocompatibility. Understanding the molecules involved in altered immune response is important for therapeutic intervention. PMMA-based membranes have adsorptive properties for uremic toxins and can modulate adaptive immune response.

BLOOD PURIFICATION (2023)

Review Surgery

Update on current and potential application of extracellular vesicles in kidney transplantation

Matteo Abinti, Evaldo Favi, Carlo Maria Alfieri, Francesca Zanoni, Silvia Armelloni, Mariano Ferraresso, Vincenzo Cantaluppi, Giuseppe Castellano

Summary: Kidney transplantation is the best treatment for end-stage kidney disease, but early diagnosis of graft injury and improving graft outcomes remain challenging. Extracellular vesicles have shown potential as precise markers of damage and therapeutic targets in the field of kidney transplantation. They can be used to determine organ quality and aging, identify transplant-related pathologies, and are suitable for drug delivery and therapy development.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Review Urology & Nephrology

Medium cut-off dialyzer for middle molecular uremic toxins in AKI and chronic dialysis

Marco Fiorentino, Francesco La Fergola, Silvia De Rosa

Summary: Uremic toxins accumulate in patients with renal failure and can cause organ dysfunction. New dialytic approaches, such as the use of medium cut-off membranes, have been proposed to improve uremic toxin removal. However, longer observational studies are needed to confirm the efficacy and safety of these membranes.

JOURNAL OF NEPHROLOGY (2023)

暂无数据